Intended for healthcare professionals

Opinion

Fair access to scarce medical capacity for non-covid-19 patients: a role for reserves

BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o276 (Published 01 February 2022) Cite this as: BMJ 2022;376:o276
  1. Govind Persad, assistant professor1,
  2. Parag A. Pathak, professor of economics2,
  3. Tayfun Sönmez, professor of economics3,
  4. M. Utku Ünver, professor of economics3
  1. 1Sturm College of Law, University of Denver
  2. 2Massachusetts Institute of Technology (MIT)
  3. 3Boston College

As hospitals in the US and elsewhere fill again with patients with covid-19, discussions about how to fairly allocate scarce medical resources have come to the fore once again. One frequently voiced concern is that non-covid-19 patients with urgent health needs are facing indefinitely postponed surgeries, long-distance hospital transfers, or even are unable to access medical treatment. In our view,12 a reserve or categorised priority system could help. It could be used to fairly distribute scarce medical capacity—such as staffing, physical space, and medical treatments—between covid-19 and non-covid-19 patients, just as it has been used or proposed to allocate covid-19 therapeutics and vaccines.3456

Before the covid-19 pandemic, some US states such as New York and Minnesota considered giving priority to health personnel in allocation guidelines for emergency ventilator scarcity, but became concerned that these essential personnel could occupy all the available ventilators in cases of extreme shortage.78 These concerns about one population group taking up all of a scarce medical resource are a recognised problem with any sort of system that prioritises access based on a single factor, such as medical prognosis. A reserve or categorised priority system would prevent this outcome by assigning some subset of available resources to first be offered to specific groups—“reserve categories”—of patients. When a surge hits, a reserve system can prioritise non-covid-19 patients for access to a subset of resources, avoiding their being denied treatment or suffering from repeated delays in accessing needed procedures, while at the same time leaving many spots open to all patients, including those with severe covid-19.

This approach could be implemented as a non-covid-19 reserve category, which could be used to ensure a basic level of access to intensive care units or hospital beds, staffing, ECMO, dialysis, medications, or any other scarce medical resource. This reserve category would be a “minimum guaranteed reserve” that ensures that non-covid-19 patients always have priority access to a subset of beds (or another scarce resource) during surges. The remaining beds could be open to both covid and non-covid patients without further prioritisation, or a separate subset of beds could be considered as a minimum guaranteed reserve for covid patients.

How large should the non-covid-19 patient reserve be? This is not a technical decision, but an ethical one. But its size might be based, for instance, on the typical number of beds occupied by non-covid-19 patients before the pandemic. The decision ultimately depends on how hospital and community decisionmakers weigh the importance of preserving access for covid-19 as opposed to non-covid-19 patients. If desired, the size or eligibility criteria for the reserve could be adjusted depending on the severity of the emergency. Even in a severe crisis, the non-covid-19 reserve could allow hospitals to quickly decide which patients go where and guarantee a basic level of access to all patients, without having to categorically exclude some groups of seriously ill patients whose needs are judged insufficiently urgent.

To protect access to medical services during surges of hospitalised unvaccinated covid-19 patients, some have instead advocated using vaccination status as a factor or a tiebreaker.9 A non-covid-19 reserve is not based on vaccination status, avoiding legal problems in jurisdictions where considering vaccination status is prohibited,10 and not presenting the ethical problems some have raised regarding the use of vaccination status in triage.11 Creating a non-covid-19 patient reserve would also allow hospitals to use specific allocation rules for distributing among covid-19 patients and patients without covid-19 respectively, while reducing the need for cross-condition comparisons (e.g., comparing patients on routine dialysis to covid-19 patients in need of acute dialysis).

While prioritising a portion of scarce treatments for non-covid-19 patients neither explicitly penalises unvaccinated patients nor rewards vaccinated ones, the latter group can be expected to benefit more from this policy. This is because vaccines’ powerful protection against severe covid-19 implies that, statistically, vaccinated people are likely to comprise a larger share of patients needing scarce medical treatment for reasons other than covid-19 than of patients needing scarce treatment for severe covid-19 infection.

In the face of covid-19 pressures on hospital capacity, a reserve system can help realise the socially valued goal of ensuring that pandemic response does not overwhelm all other medical aims and values. It is worth incorporating in many settings where decisionmakers fear that covid-19 patients will overwhelm hospital capacity. Formalising reserve categories can also help reduce the need to downgrade all care to a “contingency” level, a step which often has disproportionately bad effects on patients from minority groups experiencing discrimination and people who have serious preexisting conditions.12 If needed, a reserve system would enable the portion of scarce capacity not prioritised for non-covid-19 patients to operate at a contingency or crisis level, while the reserved portion could be effectively firewalled from the capacity pressures caused by covid-19 surges. When hospitals face ongoing surges, a reserve that protects capacity for non-covid patients could be crucial to successfully and fairly managing limited resources.

Footnotes

  • Competing interests: GP reported receiving grants from Greenwall Foundation and personal fees from ASCO Post and the World Health Organisation outside the submitted work. None further declared.

References